Synthetic THC And Blood Pressure (NCT07231965) | Clinical Trial Compass
Not Yet RecruitingPhase 2/3
Synthetic THC And Blood Pressure
United States50 participantsStarted 2026-07
Plain-language summary
To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology
Who can participate
Age range21 Years – 40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Recreational occasional Cannabis use (Consuming THC less than 2 times a week)
* 21 - 40 years of age
* Biological male or female
Exclusion Criteria
* BMI \> 35 kg/m2
* Diagnosed psychiatric disorders
* Hypotension
* History of seizures
* History of substance abuse or recreational drug use or positive urine drug screen
* History of uncontrolled disease including:
* Cardiovascular
* Pulmonary
* Gastrointestinal
* Pancreatic
* Hepatic
* Renal
* Hematological
* Endocrine (including Type I Diabetes)
* Neurological
* Urological
* Sleep disorders
* Pregnant or breastfeeding
* Use of certain antimicrobial, chemotherapeutic, anticoagulant, hypoglycemic, anti-inflammatory, psychotropic, and antihistamine drugs
* Prescribed CYP2C9 and/or CYP3A4 inhibitors
* History of shift work or rotating shifts within 1 month